Oppenheimer starts Otonomy (NASDAQ:OTIC) with an Outperform rating and $8 price target, a 217% upside. The company has a Very Bullish average Sell Side rating.
Last month, Otonomy reported mixed Q3 results that beat on EPS but missed on revenue.
OTIC shares are up 5.2% after hours to $2.65.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.